The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

Table 1 Follow-up schedule

Postoperative (years)	1			2		3		4		5
Postoperative (months)	1	6	12	18	24	30	36	42	48	54	60
Body weight Complete blood count Biochemical test Tumor markers	√	√	√	√	√	√	√	√	√	√	√
Abdominal ultrasound		√	√	√	√	√	√	√	√	√	√
Abdominal CT/MRI	√	√	√	√	√	√	√	√	√	√	√
Chest X-ray			√		√		√		√		√

ISSN: 1471-2407